English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Revenue and profitability may see 20% plus growth in FY22, says Aarti Industriesqrcode

Mar. 16, 2021

Favorites Print
Forward
Mar. 16, 2021

Follow

A McKinsey report on the Indian chemical industry reveals that the space is a consistent value creator with a positive outlook. We spoke to Rajendra V Gogri, Chairman and MD, Aarti Industries to get a sense of the on-ground situation.


On demand Gogri said, “We see more and more demand coming to India. Overall virtually we are seeing the pre-COVID demand now in Q4 or maybe Q1 of next year. Most of the discretionary sector demand has picked up.”


On capacity utilization, he said, “We are in a capex mode and we see what McKinsey report said. We are seeing lot of opportunities."


He added, “This year we will have some growth in top-line, but bottom-line will be flattish. Next year we can see 20 percent-plus growth in both top-line as well as bottom-line.”


On the PLI scheme, Gogri said, “We are not directly participating in pharma PLI but it is going to benefit the general chemical industry.”


01_副本.png 02_副本.png

Source: cnbctv18

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox